About this document

Staals 2016 by ghsuilcs is a document available to read on EtoBox.

At present, the optimal treatment strategy in patients with diffuse-type tenosynovial giant cell tumour (D-TGCT) is unclear. The purpose of this review was to describe current treatment options, and to highlight recent developments in the knowledge of the molecular pathogenesis of D-TGCT as well as related therapeutic implications. Epidemiology, clinical features, and the pathogenesis of D-TGCT and the most widely used treatment modalities are described. DTGCT is a benign clonal neoplastic proli

Author

ghsuilcs

Language

EN